Tiagabine-induced stupor in patients with psychogenic nonepileptic seizures: Nonconvulsive status epilepticus or encephalopathy?

Epilepsy and Behavior

Volumn 27, Issue 2, 2013, Pages 330-332

  Azar, Nabil J ^a   Bangalore Vittal, Nandakumar ^a   Arain, Amir ^a   Abou Khalil, Bassel W ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Encephalopathy; Myoclonus; Nonconvulsive status epilepticus; Stupor; Tiagabine

Indexed keywords

CARBAMAZEPINE; ESTRADIOL; FLUOXETINE; LORAZEPAM; PHENYTOIN; PREGABALIN; SERTRALINE; TIAGABINE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; CONFUSION; DELTA RHYTHM; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVENING DOSAGE; FEMALE; HUMAN; MALE; MORNING DOSAGE; MUSCLE TWITCH; NEUROLOGIC EXAMINATION; PSYCHOGENESIS; PSYCHOGENIC NONEPILEPTIC SEIZURE; SIDE EFFECT; STUPOR; URINE INCONTINENCE; VERBALIZATION;

ADULT; ANTICONVULSANTS; BRAIN WAVES; CONVERSION DISORDER; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROTOXICITY SYNDROMES; NIPECOTIC ACIDS; STATUS EPILEPTICUS; STUPOR; VIDEO RECORDING;

EID: 84875590996     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.02.016     Document Type: Article

References (23)

1. Krogsgaard-Larsen P., Frolund B., Frydenvang K. GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects. Curr Pharm Des 2000, 6:1193-1209.
2. Fakhoury T., Uthman B., Abou-Khalil B. Safety of long-term treatment with tiagabine. Seizure 2000, 9:431-435.
3. Leppik I.E. Tiagabine: the safety landscape. Epilepsia 1995, 36(Suppl. 6):S10-S13.
4. Uthman B.M., Rowan A.J., Ahmann P.A., et al. Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial. Arch Neurol 1998, 55:56-62.
5. Koepp M.J., Edwards M., Collins J., Farrel F., Smith S. Status epilepticus and tiagabine therapy revisited. Epilepsia 2005, 46:1625-1632.
6. de Borchgrave V., Lienard F., Willemart T., van Rijckevorsel K. Clinical and EEG findings in six patients with altered mental status receiving tiagabine therapy. Epilepsy Behav 2003, 4:326-337.
7. Kellinghaus C., Dziewas R., Ludemann P. Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 2002, 11:243-249.
8. Eckardt K.M., Steinhoff B.J. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 1998, 39:671-674.
9. Brenner R.P. The interpretation of the EEG in stupor and coma. Neurologist 2005, 11:271-284.
10. Ettinger A.B., Bernal O.G., Andriola M.R., et al. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 1999, 40:1159-1162.
11. Knake S., Hamer H.M., Schomburg U., Oertel W.H., Rosenow F. Tiagabine-induced absence status in idiopathic generalized epilepsy. Seizure 1999, 8:314-317.
12. Vinton A., Kornberg A.J., Cowley M., Matkovic Z., Kilpatrick C., O'Brien T.J. Tiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsy. J Clin Neurosci 2005, 12:128-133.
13. Mangano S., Cusumano L., Fontana A. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient. Brain Dev 2003, 25:518-521.
14. Skardoutsou A., Voudris K.A., Vagiakou E.A. Non-convulsive status epilepticus associated with tiagabine therapy in children. Seizure 2003, 12:599-601.
15. Balslev T., Uldall P., Buchholt J. Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients. Eur J Paediatr Neurol 2000, 4:169-170.
16. Fulton J.A., Hoffman R.S., Nelson L.S. Tiagabine overdose: a case of status epilepticus in a non-epileptic patient. Clin Toxicol (Phila) 2005, 43:869-871.
17. Jette N., Cappell J., VanPassel L., Akman C.I. Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy. Neurology 2006, 67:1514-1515.
18. Zhu Y., Vaughn B.V. Non-convulsive status epilepticus induced by tiagabine in a patient with pseudoseizure. Seizure 2002, 11:57-59.
19. Vollmar C., Noachtar S. Tiagabine-induced myoclonic status epilepticus in a nonepileptic patient. Neurology 2007, 68:310.
20. Jimenez-Jimenez F.J., Puertas I., de Toledo-Heras M. Drug-induced myoclonus: frequency, mechanisms and management. CNS Drugs 2004, 18:93-104.
21. Scanziani M. GABA spillover activates postsynaptic GABA(B) receptors to control rhythmic hippocampal activity. Neuron 2000, 25:673-681.
22. Semyanov A., Walker M.C., Kullmann D.M. GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 2003, 6:484-490.
23. Ostrovskiy D., Spanaki M.V., Morris G.L. Tiagabine overdose can induce convulsive status epilepticus. Epilepsia 2002, 43:773-774.